WallStreetZenWallStreetZen

NASDAQ: PTGX
Protagonist Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for PTGX

Based on 3 analysts offering 12 month price targets for Protagonist Therapeutics Inc.
Min Forecast
$37.00+29.92%
Avg Forecast
$39.00+36.94%
Max Forecast
$42.00+47.47%

Should I buy or sell PTGX stock?

Based on 3 analysts offering ratings for Protagonist Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PTGX stock forecasts and price targets.

PTGX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-11
lockedlocked$00.00+00.00%2024-03-11
lockedlocked$00.00+00.00%2024-02-28

1 of 1

Forecast return on equity

Is PTGX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is PTGX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

PTGX revenue forecast

What is PTGX's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$236.3M+293.75%
Avg 2 year Forecast
$149.7M+149.54%
Avg 3 year Forecast
$145.6M+142.69%
PTGX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PTGX revenue growth forecast

How is PTGX forecast to perform vs Biotechnology companies and vs the US market?
Company
34.38%
Industry
38.94%
Market
10.52%
PTGX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PTGX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PTGX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PTGX$28.48$39.00+36.94%Strong Buy
AUTL$6.24$10.00+60.26%Strong Buy
RCUS$18.21$38.60+111.97%Strong Buy
INBX$35.15$27.00-23.19%Buy
EWTX$17.96$33.00+83.74%Strong Buy

Protagonist Therapeutics Stock Forecast FAQ

Is Protagonist Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: PTGX) stock is to Strong Buy PTGX stock.

Out of 3 analysts, 1 (33.33%) are recommending PTGX as a Strong Buy, 2 (66.67%) are recommending PTGX as a Buy, 0 (0%) are recommending PTGX as a Hold, 0 (0%) are recommending PTGX as a Sell, and 0 (0%) are recommending PTGX as a Strong Sell.

If you're new to stock investing, here's how to buy Protagonist Therapeutics stock.

What is PTGX's revenue growth forecast for 2024-2026?

(NASDAQ: PTGX) Protagonist Therapeutics's forecast annual revenue growth rate of 34.38% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Protagonist Therapeutics's revenue in 2024 is $60,000,000.On average, 4 Wall Street analysts forecast PTGX's revenue for 2024 to be $13,767,468,278, with the lowest PTGX revenue forecast at $582,749,980, and the highest PTGX revenue forecast at $19,522,124,330. On average, 4 Wall Street analysts forecast PTGX's revenue for 2025 to be $8,725,224,076, with the lowest PTGX revenue forecast at $2,849,647,402, and the highest PTGX revenue forecast at $19,230,749,340.

In 2026, PTGX is forecast to generate $8,485,597,284 in revenue, with the lowest revenue forecast at $4,580,414,843 and the highest revenue forecast at $15,107,210,482.

What is PTGX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PTGX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is PTGX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year PTGX price target, the average PTGX price target is $39.00, with the highest PTGX stock price forecast at $42.00 and the lowest PTGX stock price forecast at $37.00.

On average, Wall Street analysts predict that Protagonist Therapeutics's share price could reach $39.00 by Mar 11, 2025. The average Protagonist Therapeutics stock price prediction forecasts a potential upside of 36.94% from the current PTGX share price of $28.48.

What is PTGX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PTGX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.